Table 2.
Association of HDV infection with liver disease progression.
| Groups | HDV/HBV coinfection | HBV monoinfection | p value | ||
|---|---|---|---|---|---|
| Clinical groups | n/total | (%) | n/total | (%) | 0.017 |
| CHB | 17/191 | 8.9 | 174/191 | 91.1 | |
| LC | 29/147 | 19.7 | 118/147 | 80.3 | |
| HCC | 25/208 | 12 | 183/208 | 88 | |
| Child-Pugh score | |||||
| Child A | 25/213 | 11.7 | 188/213 | 88.3 | 0.047 |
| Child B | 24/108 | 22.2 | 84/108 | 77.8 | |
| Child C | 3/19 | 15.8 | 16/19 | 84.2 | |
| BCLC staging | |||||
| BCLC A | 5/66 | 7.6 | 61/66 | 92.4 | NS |
| BCLC B | 13/76 | 17 | 63/76 | 83 | |
| BCLC C | 3/37 | 8 | 34/37 | 92 | |
| BCLC D | 1/10 | 10 | 9/10 | 90 | |
CHB, chronic hepatitis B; LC, liver cirrhosis; HCC, hepatocellular carcinoma; BCLC: Barcelona Clinic Liver Cancer; P values calculated by Chi-square test.